The U.S. Food and Drug Administration has asked the makers of six atypical antipsychotic drugs to update product labeling to include a warning about a possible link with diabetes, The Associated Press reported. The atypical antipsychotic drugs includes Zyprexa by Eli Lilly & Co., Clozaril by Novartis, Risperdal by Janssen, Seroquel by AstraZeneca, Geodon by [...]

Parker & Waichman LLP and Aylstock, Witkens & Sasser PLC have filed a class action lawsuit against AstraZeneca, Europe’s second largest drug maker, in a U.S. District Court on behalf of all patients who have used the popular anti-psychotic drug Seroquel. Seroquel is part of the new class of anti-psychotic drugs known as atypical anti-psychotics.
A [...]

Zyprexa, Risperdal, and Seroquel may increase a patients’ risk of developing diabetes when compared with older antipsychotic drugs like Haldol, researchers with the Department of Veterans Affairs said yesterday.
New York Times reported that, “Younger patients, under age 54, who took Zyprexa or Risperdal showed the highest risk of developing diabetes.”
The study of U.S. military [...]